US 12263165
Small molecule inhibitors of cancer stem cells and mesenchymal cancer types
granted A61KA61K31/437A61K31/4704
Quick answer
US patent 12263165 (Small molecule inhibitors of cancer stem cells and mesenchymal cancer types) held by The Board of Regents of the University of Texas System expires Mon Mar 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Apr 01 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 1
- CPC classes
- A61K, A61K31/437, A61K31/4704, A61K31/4741, A61K31/497